These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction. Ergul S; Brunson CY; Hutchinson J; Tawfik A; Kutlar A; Webb RC; Ergul A Am J Hematol; 2004 Jul; 76(3):245-51. PubMed ID: 15224360 [TBL] [Abstract][Full Text] [Related]
23. Unusual causes of abdominal pain: sickle cell anemia. Ahmed S; Shahid RK; Russo LA Best Pract Res Clin Gastroenterol; 2005 Apr; 19(2):297-310. PubMed ID: 15833695 [TBL] [Abstract][Full Text] [Related]
24. [Pathophysiology and treatment of sickle-cell disease]. van Beers EJ; Peters M; Biemond BJ Ned Tijdschr Geneeskd; 2005 May; 149(21):1144-9. PubMed ID: 15940917 [TBL] [Abstract][Full Text] [Related]
25. Role of oxidative stress in the pathogenesis of sickle cell disease. Chirico EN; Pialoux V IUBMB Life; 2012 Jan; 64(1):72-80. PubMed ID: 22131167 [TBL] [Abstract][Full Text] [Related]
26. Pathophysiology of Sickle Cell Disease. Sundd P; Gladwin MT; Novelli EM Annu Rev Pathol; 2019 Jan; 14():263-292. PubMed ID: 30332562 [TBL] [Abstract][Full Text] [Related]
27. Acute pancreatitis during sickle cell vaso-occlusive painful crisis. Ahmed S; Siddiqui AK; Siddiqui RK; Kimpo M; Russo L; Mattana J Am J Hematol; 2003 Jul; 73(3):190-3. PubMed ID: 12827657 [TBL] [Abstract][Full Text] [Related]
28. A rat model for sickle cell-mediated vaso-occlusion in retina. Lutty GA; Phelan A; McLeod DS; Fabry ME; Nagel RL Microvasc Res; 1996 Nov; 52(3):270-80. PubMed ID: 8954868 [TBL] [Abstract][Full Text] [Related]
29. Sickle cell vaso-occlusion: The dialectic between red cells and white cells. Conran N; Embury SH Exp Biol Med (Maywood); 2021 Jun; 246(12):1458-1472. PubMed ID: 33794696 [TBL] [Abstract][Full Text] [Related]
30. In vivo studies of sickle red blood cells. Kaul DK; Fabry ME Microcirculation; 2004 Mar; 11(2):153-65. PubMed ID: 15280089 [TBL] [Abstract][Full Text] [Related]
31. The possible role of red blood cell microvesicles in atherosclerosis. Blum A Eur J Intern Med; 2009 Mar; 20(2):101-5. PubMed ID: 19327596 [TBL] [Abstract][Full Text] [Related]
32. Nitric oxide loading reduces sickle red cell adhesion and vaso-occlusion in vivo. McMahon TJ; Shan S; Riccio DA; Batchvarova M; Zhu H; Telen MJ; Zennadi R Blood Adv; 2019 Sep; 3(17):2586-2597. PubMed ID: 31484636 [TBL] [Abstract][Full Text] [Related]
33. Pathophysiology and therapy for haemoglobinopathies. Part I: sickle cell disease. Madigan C; Malik P Expert Rev Mol Med; 2006 Apr; 8(9):1-23. PubMed ID: 16690007 [TBL] [Abstract][Full Text] [Related]
35. Intravascular hemolysis and the pathophysiology of sickle cell disease. Kato GJ; Steinberg MH; Gladwin MT J Clin Invest; 2017 Mar; 127(3):750-760. PubMed ID: 28248201 [TBL] [Abstract][Full Text] [Related]
36. [Current developments on sickle cell disease]. Girot R Rev Med Brux; 2005; 26 Spec no():Sp13-22. PubMed ID: 16454228 [TBL] [Abstract][Full Text] [Related]
37. Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation. Canalli AA; Franco-Penteado CF; Saad ST; Conran N; Costa FF Haematologica; 2008 Apr; 93(4):605-9. PubMed ID: 18326523 [TBL] [Abstract][Full Text] [Related]
38. The young child with sickle cell disease. Preiss DJ Adv Nurse Pract; 1998 Jun; 6(6):32-9. PubMed ID: 9708052 [TBL] [Abstract][Full Text] [Related]
39. New concepts in the immunology of sickle cell disease. Moore CM; Ehlayel M; Leiva LE; Sorensen RU Ann Allergy Asthma Immunol; 1996 May; 76(5):385-400; quiz 400-3. PubMed ID: 8630710 [TBL] [Abstract][Full Text] [Related]
40. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Ballas SK; Marcolina MJ Transfusion; 2006 Jan; 46(1):105-10. PubMed ID: 16398738 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]